Orbactiv (The Medicines Company)
Welcome to the PulseAid listing for the Orbactiv drug offered from The Medicines Company. This Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | The Medicines Company |
| NON-PROPRIETARY NAME: | oritavancin |
| SUBSTANCE NAME: | ORITAVANCIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Orbactiv HUMAN PRESCRIPTION DRUG Details:
| Item Description | Orbactiv from The Medicines Company |
| LABELER NAME: | The Medicines Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2014-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65293-015_80202a4d-bc0d-49ab-9e76-0651e5ceea79 |
| PRODUCT NDC: | 65293-015 |
| APPLICATION NUMBER: | NDA206334 |
Other ORITAVANCIN Pharmaceutical Manufacturers / Labelers:
